Home > Insider Trading > Filing (0001209191-13-035439)

Filing Details

Accession Number:: 0001209191-13-035439
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-03 15:00:14
Reporting Period:: 2013-07-01

Filing Date:: 2013-07-03
Accepted Time:: 2013-07-03 15:00:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555268	D David Davidar	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	Vice President, Operations	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2013-07-01	20,000	$16.56	15,000	No	4	S	Indirect	By Berachah Foundation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Berachah Foundation

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	1,002,275	Direct
Class A Common Stock	315,967	Indirect	By Davidar Family Irrevocable Trust U/A 8/6/09

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$4.88	2019-08-06	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$11.87	2020-06-16	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$10.66	2021-10-27	18,461	18,461	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$15.34	2022-08-29	15,000	15,000	Direct
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	$13.04	2023-01-24	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-08-06	18,461	18,461	Direct
2020-06-16	18,461	18,461	Direct
2021-10-27	18,461	18,461	Direct
2022-08-29	15,000	15,000	Direct
2023-01-24	25,000	25,000	Direct

Footnotes

This sale was pursuant to a Rule 10b5-1 Sales Plan dated May 31, 2013 and effective on June 30, 2013, which is intended to comply with Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.25 to $16.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Mr. Davidar has voting and disposition power related to these shares and disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.
These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on June 16, 2010, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.